| 摘要 |
PURPOSE: Orai1 as a marker for diagnosing cardiomyopathy is provided to use Orai1 overexpression and/or the increase of SOCE(Store-Operated Calcium Entry) due to the Orai1 overexpression. CONSTITUTION: A method for providing information on diagnosing cardiomyopathy comprises: a step of measuring an Orai1 gene expression level or protein level, and comparing the level with the gene expression level or protein level of a normal control group; and a step of measuring SOCE of a sample from a patient who is suspected to have cardiomyopathy or a patient with a mild symptom, and comparing the SOCE value with the SOCE of the normal control group. |
